What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?

MOspace/Manakin Repository

Breadcrumbs Navigation

What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/4004

[+] show full item record


Title: What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?
Author: Albrecht, Angela M.; Paulson, Christopher P.; Kovach, Fran E.
Keywords: papillary carcinoma
follicular carcinoma
thyroid remnant ablation
Date: 2009-12
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 58(12) 2009: 676d-676f.
Abstract: Recombinant human thyrotropin (rhTSH)-stimulated serum thyroglobulin (Tg) level alone is sufficient to monitor for recurrent disease in low-risk patients with a history of differentiated thyroid cancer (DTC) (strength of recommendation [SOR] A, meta-analysis). Low-risk patients are defined as patients who have undergone total thyroidectomy and radioactive iodine (I131) remnant ablation therapy and show no clinical evidence of recurrent disease.
URI: http://hdl.handle.net/10355/4004

This item appears in the following Collection(s)

[+] show full item record